←
OMass Therapeutics585 posts
OMass Therapeutics avatar

OMass Therapeutics

@omasstx
◷ Joined June 2016▧ 186 Photos and videos
BiotechTV avatar
⟳ OMass Therapeutics retweeted
BiotechTV@BiotechTV·9 Oct 2025

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Oxford, UK based @omasstx, experts in the use of mass spectrometry in drug development, recently landed a $20M up front licensing deal with Roche on one of its preclinical candidates for IBF. Full video: biotechtv.com/post/omass-the…

3:06
British Business Bank avatar
⟳ OMass Therapeutics retweeted
British Business Bank@BritishBBank·28 Jan 2025

Life sciences plays an important role in our society and economy, but it often struggles to secure funding. Ahead of our 10th anniversary, we spoke to Ros Deegan, CEO of @omasstx, about their journey and the impact of investment on life sciences. #ThePowerOf10

1:56
OMass Therapeutics avatar
OMass Therapeutics@omasstx·22 Nov 2024

Steven’s presentation, titled ‘Optimising Binding Kinetics Yields Insurmountable MC2 Receptor Antagonists for the Treatment of Diseases of ACTH Excess’ will take place at 4pm GMT on 27th November at 15Hatfields. For more information, visit: gpcrs-europe.com/speaker/ste…

Post attachment
OMass Therapeutics avatar
OMass Therapeutics@omasstx·22 Nov 2024

Our Vice President of Pharmacology and incoming CSO Steven Charlton will be presenting at the GPCRs-Targeted Drug Discovery #Summit taking place in London from 26-28 November.

OMass Therapeutics avatar
OMass Therapeutics@omasstx·3 Oct 2024

Our Senior Director of Computational Chemistry Ben Tehan will be speaking at the @MgmsUpdates Computational Drug Design #Symposium on 4 October in Stevenage. Ben’s presentation, titled ‘Molecular Dynamics in a Mass Spectrometry Company’ is at 2pm BST.

Post attachment